alphagan p
(brimonidine tartrate)Allergan, Inc.
Usage: ALPHAGAN P (brimonidine tartrate ophthalmic solution) is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
30 results
alrex
(loteprednol etabonate)Bausch & Lomb IncorporatedUsage: ALREX ophthalmic suspension is indicated for the temporary relief of signs and symptoms associated with seasonal allergic conjunctivitis.beovu
(brolucizumab)Novartis Pharmaceuticals CorporationUsage: BEOVU® is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME).bromsite
(bromfenac)Sun Pharmaceutical Industries, Inc.Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.cequa
(cyclosporine)Sun Pharmaceutical Industries, Inc.Usage: CEQUA ophthalmic solution is indicated for increasing tear production in patients with keratoconjunctivitis sicca (dry eye) as a calcineurin inhibitor immunosuppressant.cimerli
(ranibizumab-eqrn)Coherus BioSciences IncUsage: CIMERLI is indicated for treating neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.cosopt pf
(dorzolamide hydrochloride and timolol maleate)Thea Pharma Inc.Usage: COSOPT® PF is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who do not adequately respond to beta-blockers. It is typically administered twice daily and offers a different IOP-lowering effect compared to standard therapies.cystadrops
(cysteamine hydrochloride)RECORDATI RARE DISEASES, INC.Usage: CYSTADROPS is a cystine-depleting agent used to treat corneal cystine crystal deposits in adults and children with cystinosis.cystaran
(cysteamine hydrochloride)Leadiant Biosciences, Inc.Usage: CYSTARAN is indicated for treating corneal cystine crystal accumulation in patients with cystinosis, acting as a cystine-depleting agent.durysta
(bimatoprost)Allergan, Inc.Usage: DURYSTA® (bimatoprost intracameral implant) is indicated for reducing intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).